ArticleBiomedicines2022

The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis.

Adriana Celesia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.